Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Should be announcing earnings date anytime now.
yes ihub will post it here.
conference call is 5 pm est. Here is the link
http://phx.corporate-ir.net/phoenix.zhtml?c=123361&p=irol-EventDetails&EventId=4849575
sure is a long line at the exit. but its trying to go up
Greetings Marty, Thanks for the reply. Enjoy all your posts here and on other. I agree on volume and waiting after report is out, alot of people have been burned.
Concensus estimate,i believe, is .03. I'd say its about time for a turn around here. Hoping Tose can pull a rabbit out of his hat.
ok hopefully the bottom is in, 1.69 yesterday. buyers came in yesterday afternoon and this morning but then sold off. earnings are out tomorrow after close. short term should go up or sideways then its up to earnings. i'll play in at 1.71
earning out Oct. 25th might help if they are good. Or a flurry of PR's any time would help but all speculation.
cup and handle went to 2.38 then sold off.
Been falling since, fell thru the 20 dma, and today
fell thru the 50 dma. headed for the 100 dma at 1.64 unless something happens. If you want to learn about trading with charts check out Lowtrade's message board.
Good luck to you Stockslayr
You mean this Patrick Soon-Shiong
http://www.huffingtonpost.com/2012/10/03/patrick-soon-shiong_n_1935007.html
Grand kids are beautiful Low. They are a gift.
Looking to get in ONCS if it breaks .40
http://stockcharts.com/h-sc/ui?s=ONCS&p=D&yr=1&mn=0&dy=0&id=p75154207631
I cashed out today here $$$$$ :)
Been watching RFMK also, it's on my list. Their all on my list right now, haven't bought yet. Preliminary polls out says voters will pass the legalization of pot in colorado. That should be enough to send these stocks to new highs. Trying to see who plays the game the best. MJNA has put out 3 pr's in the last 4 days. CBIS fell down today.
Pot stocks are jumpin, alot going on right now
http://stockcharts.com/h-sc/ui?s=CBIS&p=D&yr=0&mn=6&dy=0&id=p38022481241
http://stockcharts.com/h-sc/ui?s=MJNA&p=D&yr=0&mn=6&dy=0&id=p99605427430
Might break that 3.15 level today.
NEW YORK --(BUSINESS WIRE)-- Faruqi & Faruqi, LLP , a leading national securities firm headquartered in New York City , is investigating the Board of Directors of Lifevantage Corporation ("Lifevantage" or the "Company") (NASDAQ: LFVN) for potential breaches of fiduciary duties in connection with their conduct of seeking shareholders' approval of the compensation for the Company's named executive officers. The terms of the compensation to be awarded to the Company's executive officers are outlined in the Proxy Statement on Form Schedule 14A that Lifevantage filed with the Securities and Exchange Commission on October 9, 2012 .
Dropped to the hard spot and bounced.
The grand opening event is this weekend in Tokyo.
sept. 19th
LifeVantage announced today that it will host a grand opening event in Tokyo on October 13 and October 14 to celebrate the official opening of its new Tokyo office. For the past two years, the Company has been selling its Nrf2 Synergizer dietary supplement Protandim® and its anti-aging skin cream LifeVantage TrueScience® into Japan using a "not-for-resale" model. Douglas C. Robinson, President and Chief Executive Officer of LifeVantage , remarked, "We anticipate that the grand opening event will be attended by several thousand independent distributors, vendors and other friends of LifeVantage. This marks an important transition point for our move to a complete "on-the-ground" presence in Japan .
Or it could be this:
LifeVantage Appoints Darlene R. Walley Ph.D. as New Chief Science Officer
Company Expands Research and Product Development for Future Growth Opportunities
SALT LAKE CITY , Oct. 12, 2012 (GLOBE NEWSWIRE) -- LifeVantage Corporation ( Nasdaq:LFVN), a company dedicated to helping people achieve healthy living through a combination of a compelling business opportunity and scientifically validated products, including its patented dietary supplement Protandim(R) , the Nrf2 Synergizer(R) , today announced Darlene R. Walley , Ph.D. will serve as the Company's new Chief Science Officer.
Dr. Walley will directly oversee the expansion of the Company's research and development as it seeks to expand its offering of scientifically validated research-backed products. Prior to joining LifeVantage , Dr. Walley was founder and president of DRW Consulting , a firm specializing in assisting large and small companies in bringing new products to market. Her clients spanned the nutraceutical, pharmaceutical and biotechnology industries. In addition, Dr. Walley has led research and development teams at Procter & Gamble , as Senior Director of Research and Development at Church & Dwight , and as Vice President of Research and Development at Gillette. Dr. Walley has a Ph.D. in Chemistry from the University of Cincinnati and a B.A. in Chemistry from Case Western Reserve .
In connection with Dr. Walley's appointment, the Company also announced today that Dr. Joe McCord will continue to work with the Company to champion third- party peer reviewed studies of the Company's flagship product Protandim and to educate the increasing number of independent distributors on the advancement of Nrf2 science. Dr. McCord will remain a key member of the Company's Scientific Advisory Board , which will be led by Dr. Walley.
"We are excited to have Darlene leading our research and development team and believe her strong background in bringing products to market combined with our leading position in Nrf2 science will enable us to expand our healthy living product offerings," said Douglas C. Robinson , President and CEO. "We want to thank Dr. McCord for his leadership as our Chief Science Officer and his enduring legacy with Protandim and are grateful that he will continue to champion Protandim in the scientific community as well as with our independent distributors on our behalf."
" LifeVantage is a fast-growing company with many opportunities, and I am eager to be a strategic member of the team," stated Darlene Walley . "I plan to utilize my background with nutraceutical and cosmeceutical product development to bring new products to market and strengthen the scientifically validated products available to LifeVantage global consumers."
LFVN accumulation into earnings has begun IMO
past two days has been a ten cent pop at the open.
If your not already in you might want to take a good look.
looks like 3.15 was the hard spot this time
Your thoughts on ONCS
http://stockcharts.com/h-sc/ui?s=ONCS&p=D&b=5&g=0&id=p29688476598
Thanx
LFVN is now available on FINVIZ.COM
http://finviz.com/quote.ashx?t=lfvn&ty=c&ta=1&p=d
Another algae story begins:
Algae Farm (usa), In (ALGF)
0.005 up 0.0048 (2400.00%)
Volume: 17,710,939
KCG has been running this morning. On a pull back right now.
HTM Something going on here. Broke UP out of my channel.
you don't need a distributor #. just go to that web page, enter your quantity and hit check out. on next page they will ask you how you heard about lifevantage. there is a pull down next to the question. click on the pull down arrow and enter "other" and the distributor # will go away.then continue with the check-out.
Its getting closer.Hope it has enough to get there.
Moving up nicely.
Beginning on September 12, 2012, shares of Lifevantage (OTC: LFVN) will commence trading on the NASDAQ under the same symbol that the stock carries now. Companies eligible for listing on the NASDAQ must meet specific criteria regarding their financials and market capitalization. Douglas Robison, President and CEO of Lifevantage, said the following, “Over the past two years we have consistently delivered strong revenue and operating growth and have taken the necessary steps to improve the overall financial health of our business.”
Traders will benefit from a NASDAQ platform that exposes orders to more liquidity and efficiencies than the over-the-counter market.
In addition to the NASDAQ news, Lifevantage released its fourth quarter and full fiscal year 2012 financial results after the close of the market yesterday. Year-over-year fourth quarter revenues increased by 197% to $144 million, and net revenues for the fiscal year grew by 224% to $120 million. The company ended FY 2012 with cash and cash equivalents of $24.6 million compared to $6.4 million in the prior year.
The double-barreled news had sellers running for cover on the opening bell. The stock began the day at $3.43, or eight cents higher than the closing price on Monday. With sellers still ducking, buyers drove share prices to $3.56 shortly after the start of the trading day. After the initial wave of buying in the first 30 minutes of trading, share prices retreated along with volume to an intraday low of $3.37 before lunchtime in New York. With food in their bellies, buyers returned to action and drove the stock higher into the closing bell. With minutes left in the trading session, the stock hit a high of $3.60 and finally closed at a price of $3.55 for a 20-cent gain. Volume on the day swamped the average daily volume of 185,000 with 1.5 million shares exchanging hands.
The stock came to life last February when the company made positive comments about projected earnings. Share prices rose from an annual low of $1.32 to a 52-week high set in March when the stock traded for $3.98. Since the spring, shares of Lifevantage have traded in a dollar range between $2.50 and $3.50. Over the last two weeks, the stock has gained nearly 17%. Is the NASDAQ listing and the earnings report enough validation of the company’s progress to push the stock higher? This is the question that traders will contemplate tonight.
Newsletter activity promoting the stock, which can be found on Stockreads.com, has remained quiet since the spring. Promoters on Stockpromoters.com, where a total of 19 promotions can be found, have been equally quiet. @InvestorsLive commented about the NASDAQ listing on Twitter, and @stockstobuy added Lifevantage as a stock to watch.
Lifevantage Corporation sells dietary supplements through the multi-level marketing industry. The company’s focus is to sell life improving and wellness products, which are sold in the United States, Mexico and Japan. Along with dietary supplements, the company also offers a product for anti-aging skin care. The company was founded in 1988 and is located in Sandy, Utah.
******WELCOME TO THE NASDAQ LFVN******
Greetings Low been learning here for years now.Thanks for everything. I am a much better trader because of you.
LFVN is one to look at I trade it constantly:
All of this came out after the close today.
10Q and uplisting to the Nasdaq.
LFVN Receives Approval to List on The Nasdaq Capital Market to begin sept. 12th 2012.
Fourth Quarter Net Revenue Increases 197% Over Prior Year Period to $44.6 Million
Fourth Quarter Operating Income Improves to a Record $7.3 Million
Company Issues Full Year Fiscal 2013 Revenue, Operating Margin, and Earning Per Share Guidance
Net revenue increased 224% to $126.2 million ;
Operating margin increased to17.0% compared to 9.5%;
Operating income grew 480% to $21.5 million ; and
Cash and cash equivalents grew to $24.6 million as of June 30, 2012 from $6.4 million as of the prior year-end.
Boy they sure nailed it, didn't they? They seem to be firing
on all cylinders right now. It will be interesting to see how
the rest of the week plays out. Good luck tradeho.
LFVN Fiscal Year 2013 Guidance
The Company anticipates continued strong growth in fiscal 2013. LifeVantage expects to generate revenue for fiscal 2013 in the range of $250 million to $260 million. The Company expects to generate operating income in the range of $34.5 million to $38.2 million, and an operating margin of 13.8% to 14.7%. The Company expects to generate earnings per diluted share in the range of $0.18 to $0.20, based on estimated weighted average diluted shares outstanding of 129 million.
LFVN Receives Approval to List on The Nasdaq Capital Market to begin sept. 12th 2012.
Fourth Quarter Net Revenue Increases 197% Over Prior Year Period to $44.6 Million
Fourth Quarter Operating Income Improves to a Record $7.3 Million
Company Issues Full Year Fiscal 2013 Revenue, Operating Margin, and Earning Per Share Guidance
Net revenue increased 224% to $126.2 million ;
Operating margin increased to17.0% compared to 9.5%;
Operating income grew 480% to $21.5 million ; and
Cash and cash equivalents grew to $24.6 million as of June 30, 2012 from $6.4 million as of the prior year-end.
ANNAPOLIS, Md. , Sept. 5, 2012 /PRNewswire/ -- TeleCommunication Systems, Inc. (TCS) (NASDAQ: TSYS), a world leader in highly reliable and secure mobile communication technology, today announced it has been selected as one of eight awardees of the Custom SATCOM Solutions (CS2) contract. This contract enables the Department of Defense (DoD) and federal civilian agencies to purchase TCS end-to-end, turnkey solutions which incorporate commercial satellite communication services through both the General Services Administration (GSA) and the Defense Information Systems Agency (DISA). The multiple-awardee, Indefinite Delivery – Indefinite Quantity (IDIQ) contract, with an estimated ceiling of $2.6 billion over five years, is part of the Future Commercial Satellite Communications Services Acquisition (FCSA) strategy established by the GSA and DISA to consolidate transponded capacity (satellite bandwidth), subscription services (including terminal and bandwidth combinations) and end-to-end solutions contracting vehicles into one program for procuring custom satellite communication solutions from a select group of qualified contractors.
Government and defense organizations are increasing their reliance on commercial satellite technology to provide essential, secure communications to the warfighter, command and control functions, and disaster recovery and response teams. According to Northern Sky Research , the global market for commercial government satellite equipment and services will grow from $4 billion in 2011 to $9.2 billion in 2019. The need for flexible, mobile wireless services drives agencies toward industry leaders like TCS and its partners for state-of-the-art solutions to reliably and securely transmit voice, video and data across the globe. TCS has a 25-year history of providing proven, reliable and cost-effective secure communication solutions for all tiers of government, and this award will broaden access by government agencies to that experience.
Supporting Quote:
TCS Senior Vice President and General Manager of Government Solutions, Michael Bristol said, "This award significantly expands TCS access to business opportunities well-suited to TCS TotalCom solutions. For the next several years, CS2 will be the main contract vehicle for the DoD and federal civilian agencies to purchase commercial satcom solutions. This contract vehicle aligns perfectly with our business model. We are a value-added systems integrator that provides mission-critical Total Communication Solutions consisting of deployable satcom equipment, managed satcom network services and field support staff."
For the past 25 years, TCS has established a proven track record as a trusted provider of communication technology solutions to solve the government's toughest technical challenges, under conditions that demand the highest level of reliability, availability and security. To ensure mission continuity, TCS TotalCom™ offers deployable, highly secure communication solutions and complete end-to-end managed services for converged (IP-based) voice, video and data solutions to organizations requiring seamless and secure connectivity between fixed sites and remote operations.
SALT LAKE CITY , Aug. 31, 2012 (GLOBE NEWSWIRE) -- LifeVantage Corporation (OTCBB:LFVN), the leader in Nrf2 science and the maker of Protandim®, the Nrf2 Synergizer® patented dietary supplement, announced today it will release financial results for its fourth fiscal quarter and full year ended June 30, 2012 , after the market closes on Monday, September 10, 2012 . The Company will hold an investor conference call at 2:30 p.m. Mountain Daylight Time ( 4:30 p.m. Eastern Daylight Time ).
ACUR looking good here.Bought some this morning and will
continue to accumulate.
JP Morgan upgrades TSYS from neutral to overweight
By the way, a friend went to a distributors' meeting on saturday and most of the talk was about Australia has already exceeded expectations.
strong finish today. dipped to the 50 dma,$2.94. Then ran back up to $3.07. Thinking that might be the last buying opportunity below $3.00. Tomorrow is another day. Preliminary earning could be any day now.
Good luck all